Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis

Published:2015-12 Issue:1 Volume:10 Page:
ISSN:1749-799X
Container-title:Journal of Orthopaedic Surgery and Research
language:en
Short-container-title:J Orthop Surg Res

Author:

Zhang Yunyuan,Ding Chunming,Wang Jing,Sun Guirong,Cao Yongxian,Xu Longqiang,Zhou Lan,Chen Xian

Funder

Shangdong Young Scientists Award Foundation

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1186/s13018-015-0328-z

Reference39 articles.

1. Siclari VA, Qin L. Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res. 2010;5:78.

2. Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, et al. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol. 2010;21:1366–73.

3. Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009;28:247–63.

4. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27:5287–97.

5. Bruland OS, Pihl A. On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer. 1997;33:1725–31.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis;Annals of Diagnostic Pathology;2023-12

2. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer;International Journal of Molecular Sciences;2023-10-31

3. CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells;International Journal of Molecular Sciences;2023-07-21

4. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma;International Journal of Molecular Sciences;2022-08-03

5. Immunotherapy in Sarcoma;Surgical Oncology Clinics of North America;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3